A Preliminary Study on Human Placental Tissue Impaired by Gestational Diabetes: A Comparison of Gel-Based versus Gel-Free Proteomics Approaches

Gestational diabetes (GDM) is the most common complication of pregnancy and it is associated with maternal and fetal short- and long-term consequences. GDM modifies placental structure and function, but many of the underlying mechanisms are still unclear. The aim of this study is to develop and compare two different methods, based respectively on gel-based and gel-free proteomics, in order to investigate the placental proteome in the absence or in the presence of GDM and to identify, through a comparative approach, possible changes in protein expression due to the GDM condition. Placenta homogenates obtained by pooling six control samples and six samples from GDM pregnant women were analyzed by two-dimensional (2D) electrophoresis coupled with mass spectrometry [nano-liquid chromatography (nano-LC) tandem mass spectrometry (MS/MS) and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS)] and by a label-free mass spectrometry method based on LC-MSE. The gel-based approach highlights 13 over-expressed proteins and 16 under-expressed proteins, while the label-free method shows the over-expression of 10 proteins and the under-expression of nine proteins. As regards 2D gel electrophoresis, a comparison between two different protein identification methods, based respectively on nLC-electrospray ionization-MS/MS and MALDI-MS/MS, was performed taking into consideration the sequence coverage, the MASCOT score and the exponentially modified protein abundance index. The analysis of the complex proteome through an integrated strategy revealed that the quantitative gel-free and label-free MS approach might be suitable to identify candidate markers of GDM.

[1]  E. Tremoli,et al.  Proteomic analysis of endothelial cell secretome: a means of studying the pleiotropic effects of Hmg-CoA reductase inhibitors. , 2013, Journal of proteomics.

[2]  Dan Golick,et al.  Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures , 2009, Proteomics.

[3]  S. Ferrara,et al.  Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation , 2011, Electrophoresis.

[4]  Bengt Persson,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[5]  H. Dihazi,et al.  Clinical proteomics--on the long way from bench to bedside? , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  E. Tremoli,et al.  Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin. , 2010, Journal of proteome research.

[7]  Z. Calay,et al.  The Incidence of Placental Abnormalities, Maternal and Cord Plasma Malondialdehyde and Vascular Endothelial Growth Factor Levels in Women with Gestational Diabetes Mellitus and Nondiabetic Controls , 2008, Gynecologic and Obstetric Investigation.

[8]  A. Mai,et al.  Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment , 2010, Proteomics. Clinical applications.

[9]  A Preliminary Investigation on Placenta Protein Profile Reveals Only Modest Changes in Well Controlled Gestational Diabetes Mellitus , 2013, European journal of mass spectrometry.

[10]  Jochen Franzen,et al.  A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics , 2003, Analytical and bioanalytical chemistry.

[11]  Bengt Persson,et al.  International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.

[12]  M. Mann,et al.  Exponentially Modified Protein Abundance Index (emPAI) for Estimation of Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides per Protein*S , 2005, Molecular & Cellular Proteomics.

[13]  Bridget B. Kelly,et al.  Recognizing global burden of cardiovascular disease and related chronic diseases. , 2012, The Mount Sinai journal of medicine, New York.

[14]  L. Schoofs,et al.  Gel-based versus gel-free proteomics: a review. , 2005, Combinatorial chemistry & high throughput screening.

[15]  M. Goshe,et al.  Improving protein and proteome coverage through data-independent multiplexed peptide fragmentation. , 2010, Journal of proteome research.

[16]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[17]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[18]  Muhammad Ashfaq,et al.  Effect of gestational diabetes and maternal hypertension on gross morphology of placenta. , 2005, Journal of Ayub Medical College, Abbottabad : JAMC.

[19]  S. Marinopoulos,et al.  Placental pathology in women with gestational diabetes , 2008, Acta obstetricia et gynecologica Scandinavica.

[20]  D. Favretto,et al.  Application of Intima Media Thickness Measurement and Omics in Intrauterine Growth Restriction Disease , 2014 .

[21]  M. Gorenstein,et al.  Absolute Quantification of Proteins by LCMSE , 2006, Molecular & Cellular Proteomics.

[22]  Jenny Renaut,et al.  Gel-Based and Gel-Free Quantitative Proteomics Approaches at a Glance , 2012, International journal of plant genomics.

[23]  E. Reece,et al.  Gestational diabetes: the need for a common ground , 2009, The Lancet.

[24]  Jean-Philippe Lambert,et al.  Proteomics: from gel based to gel free. , 2005, Analytical chemistry.

[25]  R. Thadhani,et al.  Effect of race/ethnicity on hypertension risk subsequent to gestational diabetes mellitus. , 2014, The American journal of cardiology.

[26]  T. Takizawa,et al.  Proteomics of the human placenta: promises and realities. , 2008, Placenta.

[27]  R. Bentley‐Lewis Late cardiovascular consequences of gestational diabetes mellitus. , 2009, Seminars in reproductive medicine.

[28]  E. Tremoli,et al.  A mass spectrometry-based workflow for the proteomic analysis of in vitro cultured cell subsets isolated by means of laser capture microdissection , 2014, Analytical and Bioanalytical Chemistry.

[29]  B. Liu,et al.  Altered Protein Expression in Gestational Diabetes Mellitus Placentas Provides Insight into Insulin Resistance and Coagulation/Fibrinolysis Pathways , 2012, PloS one.

[30]  K. Chaudhury,et al.  Proteomic-driven biomarker discovery in gestational diabetes mellitus: a review. , 2015, Journal of proteomics.

[31]  J. Hernández-Núñez,et al.  Utility of proteomics in obstetric disorders: a review , 2015, International journal of women's health.